Kelu Zhou
Kelu Zhou publishes mostly in Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging, on topics such as Retinal Diseases and Treatments, Peroxisome Proliferator-Activated Receptors and Retinal Development and Disorders.
- World rank
- #605,452 of 7,710,434 ranked researchers
- Rank in United States
- #207,513 of 1,627,098
- Works
- 55
- Citations
- 1.7k
- Citations per work
- 31.3
What does Kelu Zhou research?
Kelu Zhou's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (32%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2138.5%
- Medicine2138.5%
- Life Sciences1935.0%
- Everything else1526.5%
- 1Molecular Biology27% of their works
- 2Ophthalmology24% of their works
- 3Radiology, Nuclear Medicine and Imaging10% of their works
- 4Clinical Biochemistry4% of their works
- 5Immunology4% of their works
- 6Physiology4% of their works
Research topics
Which keywords describe Kelu Zhou's research?
The keywords of their largest research topics: Inflammation, Macular Degeneration, Diabetic Retinopathy, Vascular Endothelial Growth Factor, Oxidative Stress, Choroidal Thickness, Retinal Pigment Epithelium and Diabetes.
- Wnt Signaling
- HMGB1
- Adenosine Receptors
- Retinal Disease
- Deep Learning
- Gene Therapy
- Peroxisome Proliferator-Activated Receptors
- Diabetes
- Choroidal Thickness
- Vascular Endothelial Growth Factor
- Macular Degeneration
- Inflammation
- Diabetic Retinopathy
- Oxidative Stress
- Retinal Pigment Epithelium
- PPARs
- Therapeutic Targets
- Retinitis Pigmentosa
- Prematurity
- Retinopathy
- Advanced Glycation End Products
- Purinergic Signalling
- ß-Catenin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Inflammation504 topics
- Macular Degeneration403 topics
- Diabetic Retinopathy332 topics
- Vascular Endothelial Growth Factor332 topics
- Oxidative Stress322 topics
- Choroidal Thickness281 topic
- Retinal Pigment Epithelium281 topic
- Diabetes182 topics
- PPARs141 topic
- Peroxisome Proliferator-Activated Receptors141 topic
- Therapeutic Targets82 topics
- Gene Therapy71 topic
- Retinitis Pigmentosa71 topic
- Deep Learning51 topic
- Prematurity51 topic
- Retinal Disease51 topic
- Retinopathy51 topic
- Adenosine Receptors41 topic
- Advanced Glycation End Products41 topic
- HMGB141 topic
- Purinergic Signalling41 topic
- Wnt Signaling41 topic
- ß-Catenin41 topic
Where does Kelu Zhou work?
Kelu Zhou's main affiliation in the publication record is University of Oklahoma Health Sciences Center, United States.
How many publications and citations does Kelu Zhou have?
OpenAlex counts 55 works and 1,721 citations for Kelu Zhou, an h-index of 24, ranking #605,452 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kelu Zhou. Posts are plain text and can be reported.